https://www.pharmavoice.com/
Pharma Industry News | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaVoice is a leading industry publication...
pharma industrynewspharmavoice
https://www.pharmavoice.com/news/pharma-biotech-life-cycle-drug-Kura/650566/
What pharma can teach biotech about the life cycle management of a drug | PharmaVoice
Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.
life cycle managementabout thepharmateachbiotech
https://www.pharmavoice.com/events/
Upcoming events | PharmaVoice
News for pharmacy pros
upcoming eventspharmavoice
https://www.pharmavoice.com/q-and-a/
Q&A | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/selfservice/article-licensing/submit/
License our articles | PharmaVoice
News for pharmacy pros
our articleslicensepharmavoice
https://www.pharmavoice.com/news/ai-pharma-scientist-drug-research-owkin/818113/
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma? | PharmaVoice
A new tool is giving researchers a “data center full of genius Ph.D. students in their pocket.”
for pharmatackledrugmeanpharmavoice
Sponsored https://www.milfplay.com/
Milf Play OFFICIAL - Mature Dating @ Milfplay
Milfplay is the best dating site to find real local milfs for you to hook up with. Want to sext or trade pics? That's cool too. Video chat online before...
https://www.pharmavoice.com/news/rfk-peptide-pharma-drug-lilly-novo-obesity-rogan/817144/
Will RFK Jr.’s peptide push bolster the gray market for obesity drugs? | PharmaVoice
With competition fierce in the weight loss space, a potential change to how the FDA classifies peptides could increase pressure in the market even more.
rfk jrpeptidepushbolstergray
https://www.pharmavoice.com/news/jnj-plans-100b-revenue-this-year/817623/
How J&J plans to hit $100B in revenue this year | PharmaVoice
this yearplanshitrevenuepharmavoice
https://www.pharmavoice.com/news/pharmavoice100-pv100-pharma-leaders/690951/
The 2023 PharmaVoice 100 | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/news/fda-shame-game-complete-response-letters/816011/
The FDA’s shame game | PharmaVoice
The agency is becoming more open about its criticisms of pharma companies and leaders, raising new privacy concerns in the industry.
shamegamepharmavoice
https://www.pharmavoice.com/news/iran-trump-hormuz-pharma-war-shipping/816439/
How Trump’s war in Iran is scrambling pharma’s shipping options | PharmaVoice
A blockade at one of the world’s largest shipping lanes could shape the way pharma companies think about manufacturing and distribution.
war in iranshipping optionsscramblingpharmavoice
https://www.pharmavoice.com/topic/biotech-spotlight/
Biotech Spotlight | PharmaVoice
News for pharmacy pros
biotech spotlightpharmavoice
https://www.pharmavoice.com/news/trailblazers-ebrahim-delpassand-radiomedix/817050/
One doctor helped kickstart US nuclear medicine’s new wave. Now he’s refining it. | PharmaVoice
Dr. Ebrahim Delpassand, founder and CEO of RadioMedix, played a pivotal role in advancing nuclear medicine as a new-generation cancer treatment, but his work...
new waveonedoctorhelpedkickstart
https://www.pharmavoice.com/news/evommune-ipo-biotech-immunology-dupixent-ebglyss/816798/
Evommune bucked biotech IPO drought and is focused on the long game | PharmaVoice
Evommune went public late last year and is taking on stiff competition in immunology with a recent mid-stage clinical win.
the long gamebiotechipodroughtfocused
https://www.pharmavoice.com/contact/
Contact | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/topic/biotech/
Biotech and Pharma News | PharmaVoice
The latest biotech pharma news for pharma industry professionals.
biotech and pharmanewspharmavoice
https://www.pharmavoice.com/news/mrna-beyond-infectious-cancer-moderna-nih-funding/816130/
mRNA is poised to rise beyond infectious diseases, if it’s not derailed by R&D cuts | PharmaVoice
Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.
infectious diseasesmrnapoisedrisebeyond
https://www.pharmavoice.com/library/
Whitepapers, webinars, and videos | PharmaVoice
Whitepapers, webinars, videos, PDF downloads and other resources
webinars and videoswhitepaperspharmavoice
https://www.pharmavoice.com/news/cancer-drugmakers-p53-target/817469/
Will cancer drugmakers ever conquer p53? | PharmaVoice
cancereverconquerp53pharmavoice
https://www.pharmavoice.com/advertise/
PharmaVoice Advertising Page
advertising pagepharmavoice
https://www.pharmavoice.com/topic/policy-regulation/
Pharmaceutical Policy and Regulations News | PharmaVoice
The latest pharmaceutical policy and regulations news covering pharma advertising regulations, ingredient regulation, and more for pharma industry...
policy and regulationspharmaceuticalnewspharmavoice
https://www.pharmavoice.com/news/pharma-ceo-pay-2025-lilly-pfizer-abbie-gsk-jnj/817361/
5 notable pharma CEO pay hikes in 2025 | PharmaVoice
Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.”
in 2025notablepharmaceopay
https://www.pharmavoice.com/newsletter@ittnewsletter.com
Page not found | PharmaVoice
News for pharmacy pros
page not foundpharmavoice
https://www.pharmavoice.com/topic/pharma/
Pharma Sector News | PharmaVoice
The latest pharma sector and pharma industry news and updates
sector newspharma
https://www.pharmavoice.com/news/lillys-car-t-devotion-cbers-next-top-dog/818419/
Lilly’s CAR-T devotion; CBER’s next top dog? | PharmaVoice
News for pharmacy pros
cardevotionnexttopdog
https://www.pharmavoice.com/topic/first-90-days/
First 90 Days | PharmaVoice
News for pharmacy pros
first 90 dayspharmavoice
https://www.pharmavoice.com/news/houman-hemmati-cber-director-fda-regulatory/817840/
Who is Dr. Houman Hemmati, potentially CBER’s next leader? | PharmaVoice
Where the rumored frontrunner stands on key issues like vaccines and public health policy.
who isdrnextleaderpharmavoice
https://www.pharmavoice.com/signup/?signup_location=header
PharmaVoice Newsletter Sign Up
Get the free pharma newsletter trusted by industry leaders. PharmaVoice delivers the latest pharma news affecting businesses today.
newsletter sign uppharmavoice
https://www.pharmavoice.com/news/lilly-kelonia-car-t-cancer-in-vivo/818010/
Lilly’s CAR-T Kelonia deal cements Big Pharma’s in vivo push | PharmaVoice
The pharma giant’s second CAR-T deal this year, this one worth up to $7 billion, further solidifies what the industry sees as the future of genetic medicines.
in vivocardealcementsbig
https://www.pharmavoice.com/signup/?signup_location=footer-list&signup_path=/
PharmaVoice Newsletter Sign Up
Get the free pharma newsletter trusted by industry leaders. PharmaVoice delivers the latest pharma news affecting businesses today.
newsletter sign uppharmavoice
https://www.pharmavoice.com/news/roches-dac-investment-big-pharmas-lavish-ceo-bumps/817756/
Roche’s DAC investment; Big Pharma’s lavish CEO bumps | PharmaVoice
Roche is investing in new cancer-fighting technology, and some of Big Pharma's CEOs notched some noteworthy pay hikes.
dacinvestmentbiglavishceo
https://www.pharmavoice.com/news/boehringer-ingelheims-confident-obesity-metabolic-liver-drug/816744/
Boehringer Ingelheim’s confident new leap in the obesity market | PharmaVoice
With weight loss candidates still in the clinic, the company has launched a health unit aimed at the flourishing therapeutic area.
in theconfidentnewleapobesity
https://www.pharmavoice.com/news/ocugen-succeed-gene-therapy-makers-pharma-drug/815914/
Can Ocugen succeed where other gene therapy makers have struggled? | PharmaVoice
The biotech aims to quickly bring three gene therapies to market, and overcome the development and commercialization challenges that have dogged the space.
gene therapysucceedmakerspharmavoice
https://www.pharmavoice.com/news/women-revolution-menopause-pharma-drug-bayer-astellas/816871/
Women have awaited a revolution in menopause. It hasn’t arrived. | PharmaVoice
Persistent barriers are still hindering drug development for a host of menopause symptoms.
womenrevolutionmenopausearrivedpharmavoice
https://www.pharmavoice.com/news/puerto-rico-biotech-manufacturing-hub-innovation-cytoimmune/757283/
Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise | PharmaVoice
Biotechs are coming to the island as tariffs threaten overseas drug exports, and finding Puerto Rico is more than just a leading manufacturing hub.
manufacturing hubpuertoongoingjourneyinnovation
https://www.pharmavoice.com/topic/commercialization/
Pharma Commercialization News | PharmaVoice
The latest pharma commercialization news for pharma industry professionals covering drug commercialization, marketing, and launches.
pharmacommercializationnews
https://www.pharmavoice.com/news/fda-need-speed-strain-biotechs-keep-up/818468/
FDA’s need for speed could strain small biotechs. Here’s how they can keep up. | PharmaVoice
In a more politically charged environment, getting drugs across the finish line is increasingly complex and uncertain.
need for speedcouldstrainsmallbiotechs
https://www.pharmavoice.com/news/serif-flagship-biotech-startup-modified-dna-mrna/818105/
Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine | PharmaVoice
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger RNA to gene therapy.
a newseriflatestbiotechaims
Sponsored https://goloveai.com/
GoLove AI - Free AI Girlfriend App for Real Chat, Video & Photo Conversation
GoLove is an AI Girlfriend Chatbot App. Meet your Girlfriend AI and Enjoy Realistic Conversations on our Website.
https://www.pharmavoice.com/news/tariffs-trump-pharma-supreme-court-deals/816625/
Tariffs are back. What does it mean now for pharma? | PharmaVoice
While the Trump administration has again levied large new tariffs, drugmakers willing to make deals could gain some relief.
for pharmatariffsbackmeanpharmavoice
https://www.pharmavoice.com/news/big-pharma-pipeline-roche-sanofi-drug/817232/
The era of Big Pharma’s one-size-fits-all pipeline is fading | PharmaVoice
one sizeerabigfitspipeline
https://www.pharmavoice.com/press-release/
Press Releases | PharmaVoice
press releasespharmavoice
https://www.pharmavoice.com/news/gilead-end-hiv-drug-trump-pharma-funding-cut/815245/
Gilead could potentially end HIV. But will it be able to? | PharmaVoice
After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout and leveraging its network of...
couldendhivablepharmavoice
https://www.pharmavoice.com/news/pharma-diagnostics-cleveland-cancer-drug-test/818392/
Is pharma missing the boat on diagnostics? | PharmaVoice
Precision medicine is bringing pharma and diagnostics closer together, but there’s still a ways to go before the matchup is fully realized.
pharmamissingboatdiagnostics
https://www.pharmavoice.com/topic/manufacturing/
Pharmaceutical Manufacturing | PharmaVoice
The latest pharmaceutical manufacturing and drug manufacturing news for pharma industry professionals.
pharmaceutical manufacturingpharmavoice
https://www.pharmavoice.com/selfservice/event-listings/contact
List your event | PharmaVoice
News for pharmacy pros
list your eventpharmavoice
https://www.pharmavoice.com/news/novos-fda-voucher-victory-biotechs-rigid-glass-ceiling/815860/
Novo’s FDA voucher victory; biotech’s rigid glass ceiling | PharmaVoice
While Novo Nordisk collected a win through the FDA’s new voucher program, the initiative remains unpredictable and controversial.
fdavouchervictoryrigidglass
https://www.pharmavoice.com/news/insilico-brings-ai-to-womens-health-trumps-tariff-loophole-for-pharma/817148/
Biotech’s IPO comeback; Trump’s tariff loophole for pharma | PharmaVoice
Biotech IPOs gain long-lost momentum, and pharma companies find a way around the White House’s harsh tariffs.
for pharmaipocomebacktariffloophole
https://www.pharmavoice.com/news/pv100-pharma-leaders-executives/726233/
The 2024 PharmaVoice 100 | PharmaVoice
News for pharmacy pros
pharmavoice
https://www.pharmavoice.com/topic/research-development/
Pharmaceutical Research and Development News | PharmaVoice
The latest pharmaceutical research and development news for pharma industry professionals.
research and developmentpharmaceuticalnewspharmavoice
https://www.pharmavoice.com/topic/patient/
Pharma Patient News | PharmaVoice
The latest pharma patient news and updates covering the pharma patient journey, engagement, and support.
pharmapatientnews
https://www.pharmavoice.com/news/big-pharma-food-allergies-novartis-excellergy/816135/
Big Pharma goes nuts over food allergies — again | PharmaVoice
Novartis’ acquisition of Excellergy for up to $2 billion portends a potential new wave of medicines for food allergies.
big pharmafood allergiesgoesnutspharmavoice
https://www.pharmavoice.com/?page=2
Pharma Industry News | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaVoice is a leading industry publication...
pharma industrynewspharmavoice
https://www.pharmavoice.com/press-release/get-started/
Press Release Distribution Service | PharmaVoice
News for pharmacy pros
press release distributionservicepharmavoice
https://www.pharmavoice.com/about/
About Us | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry
uspharmavoice
https://www.pharmavoice.com/news/hhs-pharma-leaders-trumprx-pbm-drug-pricing-oz-cuban-means-ubl/818312/
HHS, industry leaders spar over drug pricing, TrumpRx and PBMs | PharmaVoice
Debate about drug costs erupted among prominent healthcare figures, including Dr. Oz, Mark Cuban, Calley Means and PhRMA in Washington, D.C., but they all...
industry leadersdrug pricinghhsspartrumprx
Sponsored https://www.flirt4free.com/
Free Live Sex Cams and Adult Chat | Flirt4Free
https://www.pharmavoice.com/opinion/
Opinion | PharmaVoice
News for pharmacy pros
opinionpharmavoice
https://www.pharmavoice.com/news/anthropic-coefficient-bio-pharma-drug-deal-nvidia/818599/
Why AI maker Anthropic’s deal with Coefficient Bio could be a pharma turning point | PharmaVoice
The large AI player is paying $400 million for the tiny startup, signaling a potential shift in how tech is approaching opportunities in drug development.
why aiturning pointmakerdealcoefficient
https://www.pharmavoice.com/topic/leadership/
Pharma Leadership News | PharmaVoice
The latest pharma leadership news covering the C-suite and executives of the top pharma companies.
pharmaleadershipnews
Sponsored https://adultfriendfinder.com/
AdultFriendFinder – The World’s Largest Dating and Social Discovery Site
Join the Largest Community of Fun-Loving Adults - AdultFriendFinder. Discover the excitement of connecting with millions of like-minded members on...
https://www.pharmavoice.com/news/ai-drug-discovery-pharma-immunai-pfizer-novo-nordisk-cradle/758994/
How AI advances will shape the drugmaker of the future | PharmaVoice
An AI revolution is taking place, and leaders from tech to Big Pharma are forecasting what drugmakers of the future will look like.
aiadvancesshapefuturepharmavoice
https://www.pharmavoice.com/news/ai-disease-target-pharma-drug-rd-illumina/816532/
AI’s next trick? Revealing new disease targets for drug R&D | PharmaVoice
A wave of AI-driven platforms bucks the traditional approach of hunting for new molecules and instead focuses on pinpointing the underlying cause of disease.
nexttrickrevealingnewdisease
https://www.pharmavoice.com/news/pfizer-valneva-lyme-disease-tick-vaccine/816308/
Will Pfizer’s Lyme disease gamble pay off or set the space back? | PharmaVoice
As the disease spreads into new regions, the urgency for prevention is growing.
lyme diseasethe spacegamblepayset
https://www.pharmavoice.com/editors/
Editorial Team | PharmaVoice
News for pharmacy pros
editorial teampharmavoice
https://www.pharmavoice.com/news/lsd-anxiety-definium-jnj-spravato-drug-pharma-fda/817738/
Can an LSD candidate do for anxiety what Spravato did for depression? | PharmaVoice
Definium Therapeutics is expecting late-stage data for two anxiety trials in the coming months, teeing up a potential approval.
lsdcandidateanxietyspravatodepression
https://www.pharmavoice.com/news/submit-pitches-for-pharmavoices-ongoing-series/611747/
Submit pitches for PharmaVoice’s ongoing series | PharmaVoice
Our new approach to recognizing inspiring leaders across the industry.
ongoing seriessubmitpitchespharmavoice
https://www.pharmavoice.com/news/biosimilars-traction-us-patent-thicket-scrutiny/818596/
As biosimilars gain US traction, patent thickets are under more scrutiny | PharmaVoice
A 10-year push for more biosimilars in the U.S. has led to a surge in copycat entrants, bringing more attention to the legal barriers.
biosimilarsgainustractionpatent
https://www.pharmavoice.com/profiles/
Profiles | PharmaVoice
News for pharmacy pros
profilespharmavoice
https://www.pharmavoice.com/news/new-fda-guidance-clinical-trials-bayesian/811755/
New FDA guidance that’s a ‘huge deal’ for clinical trials | PharmaVoice
Why using Bayesian statistics could transform trial design for rare diseases and beyond.
clinical trialsnewfdaguidancepharmavoice